Willem Rijnbout St James

Community-oriented graduate researcher with expertise in communication, experimental design/execution, and data analysis. Proven ability to present complex findings clearly and contribute positively as a team player. Expertise in both in vivo and in vitro preclinical models, emphasizing statistical analysis and data interpretation. Aims to leverage strong analytical skills, collaborative spirit, and interpersonal abilities to drive impactful research outcomes.

• 2025, Defining the Aryl Hydrocarbon Receptor as a Driver of Pulmonary Fibrosis, Poster presented at the Rare Disease Research Day (RareDIG) at the Montreal Neurological Institute.
• 2024, The Aryl Hydrocarbon Receptor: Implications in Pulmonary Fibrosis., Poster presented at Meakins Christie Laboratories Respiratory Research Day.
• 2023, The Aryl Hydrocarbon Receptor: New Implications in Fibrosis., Poster presented at 50th Anniversary Research Conference of the Meakins Christie Laboratories.
• 2022, Plasma Levels of Collagen Triple Helix Repeat Containing 1 (CTHRC1) as a Potential Biomarker in Interstitial Lung Disease., Abstract accepted to ICBCM 2022: International Conference on Biomarkers and Clinical Medicine.
• 2021, Plasma Levels of Collagen Triple Helix Repeat Containing 1 (CTHRC1) in an Interstitial Lung Disease Cohort., Poster presented at the 2021 College of Arts and Sciences Spring Research Symposium, University of New England, Biddeford, ME.
• 2020, CTHRC1 regulation of NFkB pathway in vascular remodeling resulting from chronic age-related inflammation., Poster presented at the 2020 College of Arts and Sciences Fall Research Symposium, University of New England, Biddeford, ME.

• Scireq FlexiVent (Murine Pulmonary Function Analysis)
• Zeiss Confocal Laser Scanning Microscope 780/800
• BioRad ChemiDoc Chemiluminescence Imaging System

• 01/01/23, Meakins-Christie Laboratories 2023 Collaborative Research Award, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
• 01/01/22, Best in Medicine and Health Science at the International Conference on Biomarkers and Clinical Medicine., "Plasma Levels of Collagen Triple Helix Repeat Containing 1 (CTHRC1) as a Potential Biomarker in Interstitial Lung Disease"
• 01/01/22, Summa Cum Laude (High Honours), University of New England, Biddeford, Maine, USA
• 01/01/22, Dean's Honors list, University of New England, Biddeford, Maine, USA, 2018 - 2022

01/01/23, Alluli, A., Rijnbout St James, W., Eidelman, D. H., Baglole, C. J., Dynamic relationship between the aryl hydrocarbon receptor and long noncoding RNA balances cellular and toxicological responses., Biochemical pharmacology, 216, 115745, https://doi.org/10.1016/j.bcp.2023.115745

• 01/01/25, W. Rijnbout St James, E. Wilson, E. Marcotte, J. Ding, P. Nair, D. H. Eidelman, C. Baglole, Defining the Aryl Hydrocarbon Receptor as a Driver of Pulmonary Fibrosis., American Thoracic Society. Cellular/Molecular Investigation /Respiratory Cell and Molecular Biology (RCMB) Group.
• 01/01/22, Rijnbout-St.James Willem, Lindner Volkhard, Scholand Mary Beth, Ashton M. Tillett, DiGennaro Michael Jude, Smith Silvia Enrica, Plasma Levels of Collagen Triple Helix Repeat Containing 1 (CTHRC1) as a Potential Biomarker in Interstitial Lung Disease., World Academy of Science, Engineering and Technology. International Journal of Biomedical and Biological Engineering., 16, 03, 2022

• Masters of Science (M.Sc.), Pathology, McGill University, 09/01/22, Present, Montreal, Quebec, Canada
• Bachelor of Science (B.Sc.), Medical Biology, University of New England, 09/01/17, 05/01/21, Biddeford, Maine, USA

• ICH Guidance E6(R2) GCP (International Council for Harmonisation-Good Clinical Practice) - CANTRAIN | Clinical Trials Training Programs (Credential ID 1672 SA.L2.C1.EN.V1)

• Avid rock climber and home cook